Japanese Insurance Stock News

Metaplanet Inc. recently held board meetings where it approved dividends of JPY 12.25 per Class B preferred share across three record dates in 2026 and moved to revise the floor exercise price of its 27th Series Stock Acquisition Rights from JPY 298 to JPY 187. Together, these actions highlight how Metaplanet is simultaneously returning capital to preferred shareholders while adjusting equity incentive terms, which can reshape perceptions of its financing and capital structure. Next, we will...

Kanadevia Corporation ( TSE:7004 ) shareholders will have a reason to smile today, with the covering analyst making...

ITOCHU Corporation ( TSE:8001 ) just released a solid earnings report, and the stock displayed some strength. While the...

Ajinomoto Co., Inc.'s ( TSE:2802 ) robust earnings report didn't manage to move the market for its stock. Our analysis...

Rising inflation signals, tighter central bank policies and shifting government bond markets are pushing many investors to focus on quality first. In this setting, stocks with high return on equity, solid past performance and strong balance sheets can help you stay focused on businesses that already show financial discipline. The Solid Balance Sheet and Fundamentals screener is designed exactly for that, filtering for companies that pair profitability with sound funding and asset strength. In...

OSG (TSE:6136) has drawn fresh attention after recent share price moves. This is prompting a closer look at how its current valuation lines up with its earnings profile, geographic mix and measured revenue and net income growth. See our latest analysis for OSG. At a share price of ¥3,661.0, OSG has seen strong recent momentum, with a 90 day share price return of 43.96% and a 1 year total shareholder return of 127.00%, which puts recent moves into the context of a much longer upswing. If this...

In mid-June 2026, Japan’s Fair Trade Commission raided Morinaga Milk Industry and five other ice cream makers over suspected long-running price fixing, with all firms pledging to cooperate with the antitrust probe. The investigation, described locally as a potential price cartel involving senior executives, raises significant questions about Morinaga’s pricing practices, governance culture, and future regulatory scrutiny. We’ll now examine how the alleged price-fixing probe, and the scrutiny...

Rakus (TSE:3923) reported preliminary unaudited consolidated sales of ¥4,729 million for May 2026, equal to 102.1% year on year, giving investors fresh monthly insight into the cloud and IT outsourcing provider’s recent trading momentum. See our latest analysis for Rakus. Rakus shares are trading at ¥917.8, with a 90 day share price return of 24.68%. However, the year to date share price return is down 11.88% and the 1 year total shareholder return is down 19.09%, suggesting recent momentum...

Nomura Research Institute, Ltd. recently held board meetings to cancel treasury stock and to approve the reintroduction of its trust-type Employee Shareholding Incentive Plan (E-Ship®), which uses a dedicated trust to acquire and allocate company shares to employee association members over time. This renewed E-Ship® structure is designed to more closely align employee ownership with the company’s Vision 2030 and medium- to long-term goals, while potentially affecting capital allocation...

Keyence recently disclosed that it is considering reducing its minimum investment unit to improve stock liquidity and make its shares more accessible to individual investors in Japan. This review of trading lots highlights how Keyence is aligning with broader efforts in Japan to encourage greater retail participation in equity markets. We will now examine how Keyence’s potential reduction in its minimum investment unit could influence the company’s broader investment narrative. The future of...

Deciphera Pharmaceuticals, a member of Ono Pharmaceutical, recently dosed the first patient in INTREPID, a global pivotal Phase 3 trial of sapablursen for polycythemia vera, a rare and potentially life‑threatening blood disease. This milestone highlights Ono Pharmaceutical’s push to expand its pipeline in rare hematologic conditions with an investigational once‑monthly treatment approach that could address meaningful unmet medical needs. We’ll now explore how progress in this Phase 3...

As global markets navigate a complex landscape marked by steady interest rates in the U.S., rising rates in Japan, and mixed economic data across Europe and China, investors are keenly assessing opportunities for value. In such an environment, identifying stocks that are trading below their intrinsic value can be particularly appealing, as these may offer potential for growth when market conditions stabilize.

As global markets navigate a complex landscape marked by steady interest rates from the Federal Reserve and rising short-term yields, small-cap stocks have shown resilience, with the Russell 2000 Index gaining 20.06% year-to-date. In this environment, investors are increasingly on the lookout for undiscovered gems—small-cap companies that demonstrate strong fundamentals and potential for growth amid broader economic shifts.

As global markets navigate a complex landscape of steady U.S. interest rates, rising Japanese borrowing costs, and mixed economic signals from Europe and China, investors are keenly focused on strategies that can provide stability amidst volatility. In this environment, dividend stocks stand out as they offer the potential for regular income while also providing opportunities for growth; their appeal is particularly strong when central banks' policies create uncertainty in traditional income...

MIRAI (TSE:3476) has just posted its H1 2026 scorecard, with total revenue of ¥5,925.6 million and trailing twelve month basic EPS of ¥1,297.13, set against a prior half year where revenue was ¥6,027.9 million and EPS was ¥1,348.59, and a year earlier when revenue was ¥6,201.0 million and EPS was ¥1,256.66. These figures sit within a broader context of modest forecast revenue and earnings growth, while consistently high margins shape how investors interpret this latest set of results. See our...

Ichigo Office REIT Investment (TSE:8975) has reported its H1 2026 results with recent half year revenue at ¥9.3 billion and basic EPS at ¥2,700.30, while trailing twelve month revenue stands at ¥19.5 billion with basic EPS of ¥6,029.68, compared with ¥17.3 billion and EPS of ¥4,782.13 a year earlier. Against this backdrop of higher trailing net profit margins and reported earnings growth, the latest numbers position Ichigo Office REIT Investment as a REIT where investors are likely to focus...

Tosei Reit Investment (TSE:3451) opened H1 2026 with steady top line momentum, reporting half-year revenue of ¥3,727 million and basic EPS of ¥3,872.97. This was set against a trailing twelve-month revenue base of ¥7,420 million and EPS of ¥7,684.85. Over recent halves the company has seen revenue move from ¥3,662 million in H2 2024 to ¥3,693 million in H1 2025 and then ¥3,727 million in H2 2025. Basic EPS has tracked from ¥3,761.40 to ¥3,811.88 and then ¥3,872.97, giving investors a picture...

KDX Realty Investment (TSE:8972) has opened FY 2026 with Funds From Operations of ¥20.7 billion and net income of ¥17.0 billion on revenue of ¥39.9 billion for the first half, alongside basic EPS of ¥4,202.90. Looking back, the company reported revenue of ¥39.4 billion with EPS of ¥4,169.32 in the first half of FY 2025 and ¥38.8 billion with EPS of ¥4,153.67 in the second half. Its trailing 12 month revenue is ¥78.7 billion with EPS of ¥8,356.46. For investors, the latest release highlights...

Visional, Inc. reported past earnings for the nine months ended April 30, 2026, with sales rising to ¥73,157 million and net income to ¥14,214 million, alongside higher basic and diluted earnings per share from continuing operations. The results highlight that Visional increased both revenue and profitability over the prior-year period, indicating improved operating efficiency and earnings power. With this backdrop of higher year-on-year sales and net income, we will explore how Visional’s...

Japan’s inflation and interest rate picture is shifting, with core consumer inflation at 1.4% and the Bank of Japan lifting rates to a 31 year high while wholesale prices and energy costs press higher. For investors in Japanese consumer staples, that mix can change how resilient everyday goods producers really are when input costs and borrowing terms move. This article looks at three stocks from a Japanese Consumer Staples Stocks screener that appear positively exposed to the current news...

PARK24 (TSE:4666) is back in focus after raising its full year earnings guidance, reflecting better than expected interim results tied to UK restructuring effects and a substantial deferred tax gain. See our latest analysis for PARK24. The raised guidance has come alongside strong recent share price momentum, with a 20.78% 1 month share price return and a 17.57% 7 day share price return, contributing to a 19.66% 1 year total shareholder return that suggests improving sentiment toward...

Fujitsu (TSE:6702) is in focus after its board moved to amend the slate of director candidates by withdrawing the planned reappointment of Hidenori Furuta, following findings of inappropriate conduct and his request to resign. See our latest analysis for Fujitsu. The governance news lands at a time when Fujitsu’s share price has fallen 23% year to date, yet the 3 year total shareholder return of 84% and 5 year total shareholder return of 77% still point to a strong longer run outcome. If you...

Fuso Chemical Co., Ltd. recently raised its consolidated earnings guidance for the six months to September 30, 2026 and the full fiscal year to March 31, 2027, keeping net sales and operating profit forecasts unchanged while significantly lifting profit attributable to owners of parent and earnings per share targets. This unusual combination of steady sales and operating profit forecasts but higher bottom-line expectations points to improved assumptions for profitability drivers such as...

Nippon Steel (TSE:5401) is in focus after outlining plans to invest up to US$2.5b in U.S. Steel’s Pennsylvania operations, targeting a new hot strip mill and efficiency upgrades for higher value steel products. See our latest analysis for Nippon Steel. At a share price of ¥566.8, Nippon Steel has seen short term momentum pick up, with a 1 day share price return of 1.67% and 7 day share price return of 5.94%. This is occurring even though the 90 day share price return is down 4.37% and the...